AKEBIA THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $57.9M | $55.2M | $2.7M | $5.8M |
| FY2017 | $-56.2M | $-57.8M | $1.6M | $8.9M |
| FY2018 | $-97.5M | $-99.1M | $1.6M | $19.0M |
| FY2019 | $-257.4M | $-264.1M | $6.7M | $11.9M |
| FY2020 | $-110.4M | $-110.7M | $317.0K | $24.5M |
| FY2021 | $-253.0M | $-253.0M | $59.0K | $22.7M |
| FY2022 | $-73.2M | $-73.3M | $114.0K | $17.8M |
| FY2023 | $-23.4M | $-23.4M | $0 | $9.3M |
| FY2024 | $-40.7M | $-40.7M | $33.0K | $7.8M |
| FY2025 | $68.0M | $67.7M | $291.0K | $11.3M |